Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2015 2
2016 2
2018 2
2019 2
2021 6
2022 5
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists.
Boshchenko AA, Maslov LN, Mukhomedzyanov AV, Zhuravleva OA, Slidnevskaya AS, Naryzhnaya NV, Zinovieva AS, Ilinykh PA. Boshchenko AA, et al. Among authors: naryzhnaya nv. Int J Mol Sci. 2024 Apr 30;25(9):4900. doi: 10.3390/ijms25094900. Int J Mol Sci. 2024. PMID: 38732142 Free PMC article. Review.
The role of β-adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β-adrenergic receptor agonists and antagonists protect the heart?
Maslov LN, Naryzhnaya NV, Voronkov NS, Kurbatov BK, Derkachev IA, Ryabov VV, Vyshlov EV, Kolpakov VV, Tomilova EA, Sapozhenkova EV, Singh N, Fu F, Pei J. Maslov LN, et al. Among authors: naryzhnaya nv. Fundam Clin Pharmacol. 2024 Feb 29. doi: 10.1111/fcp.12988. Online ahead of print. Fundam Clin Pharmacol. 2024. PMID: 38423796 Review.
Angiotensin 1-7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart-The signaling mechanism.
Derkachev IA, Popov SV, Maslov LN, Mukhomedzyanov AV, Naryzhnaya NV, Gorbunov AS, Kan A, Krylatov AV, Podoksenov YK, Stepanov IV, Gusakova SV, Fu F, Pei JM. Derkachev IA, et al. Among authors: naryzhnaya nv. Fundam Clin Pharmacol. 2024 Jun;38(3):489-501. doi: 10.1111/fcp.12983. Epub 2024 Feb 4. Fundam Clin Pharmacol. 2024. PMID: 38311344 Review.
A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena.
Maslov LN, Naryzhnaya NV, Popov SV, Mukhomedzyanov AV, Derkachev IA, Kurbatov BK, Krylatov AV, Fu F, Pei J, Ryabov VV, Vyshlov EV, Gusakova SV, Boshchenko AA, Sarybaev A. Maslov LN, et al. Among authors: naryzhnaya nv. J Biomed Res. 2023 Jul 28;37(4):281-302. doi: 10.7555/JBR.37.20230021. J Biomed Res. 2023. PMID: 37503711 Free PMC article.
KATP channels are regulators of programmed cell death and targets for the creation of novel drugs against ischemia/reperfusion cardiac injury.
Maslov LN, Popov SV, Naryzhnaya NV, Mukhomedzyanov AV, Kurbatov BK, Derkachev IA, Boshchenko AA, Prasad NR, Ma H, Zhang Y, Sufianova GZ, Fu F, Pei JM. Maslov LN, et al. Among authors: naryzhnaya nv. Fundam Clin Pharmacol. 2023 Dec;37(6):1020-1049. doi: 10.1111/fcp.12924. Epub 2023 Jun 26. Fundam Clin Pharmacol. 2023. PMID: 37218378 Review.
Association of Epicardial Adipose Tissue Adipocytes Hypertrophy with Biomarkers of Low-Grade Inflammation and Extracellular Matrix Remodeling in Patients with Coronary Artery Disease.
Kologrivova IV, Naryzhnaya NV, Koshelskaya OA, Suslova TE, Kravchenko ES, Kharitonova OA, Evtushenko VV, Boshchenko AA. Kologrivova IV, et al. Among authors: naryzhnaya nv. Biomedicines. 2023 Jan 17;11(2):241. doi: 10.3390/biomedicines11020241. Biomedicines. 2023. PMID: 36830779 Free PMC article.
28 results